A framework to avoid irrational polypharmacy in psychiatry

J Psychopharmacol. 2012 Dec;26(12):1507-11. doi: 10.1177/0269881112453211. Epub 2012 Jul 5.

Abstract

Many patients with psychiatric disorders do not obtain remission from available pharmacological and psychotherapeutic treatments. Recent studies have demonstrated that there is a role for the rational use of 'combination therapy' when treating patients with serious and treatment-resistant mental illnesses. When prescribing multiple medications, it is easy, however, to fall into irrational polypharmacy. We present a framework that clinicians can use to avoid the pitfall of irrational polypharmacy. When using combination therapy, clinicians should consider: (a) pharmadynamic redundancy; (b) pharmacodynamic interactions; (c) pharmacokinetic interactions; and (d) avoid inadequate dosing of medications. Clinicians should also (e) regularly reassess the need for and benefit of continued combination therapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Drug Therapy, Combination
  • Humans
  • Inappropriate Prescribing / prevention & control
  • Mental Disorders / drug therapy*
  • Polypharmacy
  • Practice Guidelines as Topic
  • Practice Patterns, Physicians'*
  • Psychotropic Drugs / administration & dosage
  • Psychotropic Drugs / pharmacokinetics
  • Psychotropic Drugs / therapeutic use*

Substances

  • Psychotropic Drugs